| Quarter (USD) | Dec 22 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Annual (USD) | Dec 22 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 574 |
| Opened positions | 70 |
| Closed positions | 68 |
| Increased positions | 178 |
| Reduced positions | 193 |
| 13F shares | Current |
|---|---|
| Total value | 5.38 tn |
| Total shares | 2.96 bn |
| Total puts | 16.00 k |
| Total calls | 148.70 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| PFE Pfizer | 2.06 bn | $22.05 bn |
| GSK GSK | 385.32 mm | $3.27 bn |
| Dodge & Cox | 179.17 mm | $1.90 tn |
| FMR | 104.92 mm | $1.11 tn |
| Clearbridge Advisors | 37.37 mm | $395.38 bn |
| Harding Loevner | 24.89 mm | $263.22 bn |
| Fisher Asset Management | 13.68 mm | $144.76 bn |
| Wellington Management | 9.15 mm | $96.83 bn |
| Aristotle Capital Management | 8.99 mm | $95.11 bn |
| Sculptor Capital | 8.89 mm | $94.03 bn |
